Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 10965.40 58.45 0.54%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA)

 

DUSA Share Price

Open 22.58 Change Price %
High 22.65 1 Day 0.01 0.04
Low 22.58 1 Week 0.00 0.00
Close 22.65 1 Month 0.44 1.98
Volume 23758 1 Year 14.65 183.12
52 Week High 22.68
52 Week Low 19.79
 
DUSA Technical Analysis
5
As on 31st Oct 2017 DUSA Share Price closed @ 22.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 19.07 & Strong Buy for SHORT-TERM with Stoploss of 21.65 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 45.49 2.52%
 
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
 
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
 
 
DUSA
Daily Charts		 DUSA
Intraday Charts		 Whats New @
Bazaartrend		 DUSA
Free Analysis
 
DUSA Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE22.71
RESISTANCE22.69
SUPPORT22.61
SUPPORT22.59
SUPPORT0.00
SUPPORT0.00
 
DUSA Target for Month January
Share
4th UP TARGET24
3rd UP TARGET23.57
2nd UP TARGET23.3
1st UP TARGET23.03
1st DOWN TARGET22.27
2nd DOWN TARGET22
3rd DOWN TARGET21.73
4th DOWN TARGET21.3
 
DUSA Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
DUSA Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
DUSA Other Details
Segment EQ
Market Capital 155506272.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
 
DUSA Address
DUSA
 N/A
 
DUSA Latest News
 
Your Comments and Response on DUSA Pharmaceuticals, Inc.
 
DUSA Business Profile
DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company�s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. During the year ended December 31, 2011, it initiated an exploratory DUSA-sponsored clinical trial designed to study the broad area application and/or short drug incubation (BASDI), method of using the Levulan Kerastick, which is being carried out at 10 clinical trial sites. DUSA manufactures its Levulan Kerastick in its Wilmington, Massachusetts facility. Its wholly owned subsidiaries include DUSA Pharmaceuticals New York, Inc. and Sirius Laboratories, Inc. As of December 31, 2011, DUSA ceased marketing and selling its remaining Non-PDT products, which were ClindaReach and Meted.
 
© 2005-2018 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service